ASSET TRANSFER AGREEMENTAsset Transfer Agreement • January 20th, 2012 • Astex Pharmaceuticals, Inc • Pharmaceutical preparations • Delaware
This Asset Transfer Agreement (the “Transfer Agreement”) is entered into as of January 13, 2012 (“Execution Date”), by and between GlaxoSmithKline LLC, a Delaware limited liability company, with its principal place of business located at One Franklin Plaza, Philadelphia, Pennsylvania 19101 (“GSK”) and Astex Pharmaceuticals, Inc., a company organized under the laws of Delaware, with its principal place of business located at 4140 Dublin Blvd., Ste. 200, Dublin, CA 94568 (formerly SuperGen, Inc.), (“Astex”). Each of GSK and Astex are hereinafter referred to as a “Party” and together, the “Parties”.
GSK LETTERHEAD]Astex Pharmaceuticals, Inc • January 20th, 2012 • Pharmaceutical preparations
